Safety and effectiveness of insulin aspart in Basal-bolus regimens regardless of age: a1chieve study results.

ABSTRACT:

Introduction

Hypoglycemia is a complication in the management of type 2 diabetes, and elderly people are at greater risk of experiencing hypoglycemia events than younger patients. Insulin analogs achieve glycemic control with minimal risk of hypoglycemia and may therefore be a good treatment option for all patients.

Methods

A1chieve was an international, multicenter, prospective, open-label, non-interventional, 24-week study in people with type 2 diabetes who started/switched to therapy with biphasic insulin aspart 30, insulin detemir or insulin aspart (alone/in combination) in routine clinical practice. This sub-analysis evaluated clinical safety and effectiveness of insulin aspart as part of a basal-bolus regimen (±oral glucose-lowering drugs) in three age-groups (≤40, >40

SUBMITTER: Latif ZA 

PROVIDER: S-EPMC3687088 | biostudies-literature | 2013 Jun

REPOSITORIES: biostudies-literature